Evidence map›Paper›PMID 33629231›Full record

Observational studyJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract2021

T1 Rectal Adenocarcinoma: a Different Way to Measure Tumoral Invasion Based on the Healthy Residual Submucosa with Its Prognosis and Therapeutic Implications.

Alex Casalots, Xavier Serra-Aracil, Laura Mora-Lopez, Albert Garcia-Nalda, Carles Pericay, Joan Carles Ferreres, Salvador Navarro-Soto

2 registry-linked trialsAbstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06218108 unknown statusnot on this mapstarted 2023, after this paper: background citation

Multicenter Observational Study on the Taulí-T1 Classification for Staging, Prognosis, and Management of pT1 Rectal Adenocarcinoma (TAUTEM-pT1 Study)

TypeobservationalSponsorCorporacion Parc TauliRan2023 to 2026Enrolled317ConditionsRectal Cancer Stage IArmsTaulí-T1 versus conventional classifications
NCT06450574 phase3not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Prospective, Controlled and Randomized Phase III Multicentric Study of the Treatment of T1,N0,M0 Rectal Cancer. Neoadjuvant Therapy and Transanal Endoscopic Surgery vs. Transanal Endoscopic Surgery (TAUTEM-T1 Study)

TypeinterventionalSponsorCorporacion Parc TauliRan2024 to 2027Enrolled106ConditionsRectal Cancer Stage IArmsCapecitabine (Xeloda), 50.4 Gy, Transanal Endoscopic Microsurgery (TEM), Transanal Endoscopic Microsurgery
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Alex CasalotsPathology Department, Parc Tauli University Hospital, Sabadell, Sabadell, Barcelona, Spain.
Xavier Serra-AracilColoproctology Unit, General and Digestive Surgery Department, Parc Tauli University Hospital, Sabadell, Parc Tauli s/n, 08208, Sabadell, Barcelona, Spain. xserraa@gmail.com.ORCID 0000-0003-0291-1900
Laura Mora-LopezColoproctology Unit, General and Digestive Surgery Department, Parc Tauli University Hospital, Sabadell, Parc Tauli s/n, 08208, Sabadell, Barcelona, Spain.
Albert Garcia-NaldaColoproctology Unit, General and Digestive Surgery Department, Parc Tauli University Hospital, Sabadell, Parc Tauli s/n, 08208, Sabadell, Barcelona, Spain.
Carles PericayMedical Oncology Department, Parc Tauli Hospital Universitari. Institut d'Investigació i Innovació Parc Tauli I3PT., Sabadell, Barcelona, Spain.
Joan Carles FerreresPathology Department, Parc Tauli University Hospital, Sabadell, Sabadell, Barcelona, Spain.
Salvador Navarro-SotoColoproctology Unit, General and Digestive Surgery Department, Parc Tauli University Hospital, Sabadell, Parc Tauli s/n, 08208, Sabadell, Barcelona, Spain.
Deleted InstitutionHospital de Sabadell · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurgical treatment of early rectal cancer T1 is either local excision or total mesorectal excision. The choice of surgery is based on the risk of metastatic lymph node involvement. The most important factor to consider is the degree of submucosal invasion. We present a different way to measure tumoral invasion derived from the measurement of the healthy residual submucosa with its prognosis and therapeutic implications

methodsObservational study of tumor submucosal invasion in patients undergoing transanal endoscopic microsurgery was conducted. Parameters evaluated are submucosal invasion, measuring the healthy residual submucosa at the point of maximum invasion; macroscopic morphology of the tumor; presence of muscularis mucosa, muscularis propria, and measurement of submucosa in the tumor area and the healthy area. The classification proposed is compared with the ones previously published.

resultsEighty consecutive patients diagnosed with T1 rectal cancer underwent transanal endoscopic microsurgery. Seventeen tumors (21.3%) were polypoid. En bloc resection was achieved in 77 (96.3%). The muscularis mucosa was present in 28 (35%), and the muscularis propria in 77 (96.3%) (p < 0.001). The healthy residual submucosa in the tumor area measured 2,343 ± 1,869 μm. Agreement was moderate with the Kikuchi classification (kappa 0.58) and very good with the Kudo classification (kappa 0.87).

conclusionsWe describe a method for measuring submucosal invasion in T1 rectal cancer which does not depend on the morphology of the lesion or on the presence of the muscularis mucosa. It can be applied to all T1 classifications of the digestive tract in which the muscularis propria is present.

Indexed as

AdenocarcinomaRectal NeoplasmsTransanal Endoscopic MicrosurgeryHumansNeoplasm InvasivenessPrognosisEarly invasive rectal adenocarcinomaPrognosis of T1 rectal adenocarcinomaSubmucosal invasionT1 rectal adenocarcinomaTEMTEO

Identifiers

PMID33629231
OpenAlexW3130194297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.